End-Stage Kidney Failure

Symptoms like poor appetite, nausea and stress may be more common with severe chronic kidney disease and reduce quality of life in patients not on dialysis, data show.

The transplant community, HHS and procurement organizations need to work collaboratively to increase the organ supply for transplantation in the United States, according to remarks made at the American Transplant Congress.

The use of SGLT2 inhibitors with type 2 diabetes is associated with lower risks for end-stage renal disease and acute renal failure compared with DPP-IV inhibitor use, according to study findings from Hong Kong.

The Committee for Medicinal Products for Human Use recommended approval of Kapruvia as the first therapy in Europe for chronic kidney disease-associated pruritus in patients on hemodialysis, according to a release.

Vantage Health announced its partnership with Fresenius Medical North America and a new care agreement aimed at improving outcomes for patients with late-stage chronic kidney disease, according to a company press release.

CVD leads to approximately 40% to 50% of deaths in patients with advanced chronic kidney disease or end-stage renal disease, so CV risk assessment of recipients and donors is an important part of the kidney transplantation process.

Cara Therapeutics Inc. announced that Korsuva injection received CMS transitional drug add-on payment adjustment in the anti-pruritic functional category.

Urinary VEGF levels were lower in premature infants with severe lung disease who developed chronic kidney disease compared with those who did not develop CKD, implying VEGF may be a biomarker of CKD in this patient population.